PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
This Quarter Return
-2.59%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.33B
AUM Growth
+$1.33B
Cap. Flow
+$73.5M
Cap. Flow %
5.54%
Top 10 Hldgs %
38.03%
Holding
288
New
61
Increased
32
Reduced
61
Closed
45

Sector Composition

1 Healthcare 82.38%
2 Consumer Staples 1.98%
3 Technology 1.76%
4 Industrials 1.72%
5 Materials 1.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BIIB icon
176
Biogen
BIIB
$19.4B
0
CGEN icon
177
Compugen
CGEN
$132M
0
CLOV icon
178
Clover Health Investments
CLOV
$1.34B
0
CLSD icon
179
Clearside Biomedical
CLSD
$28.9M
0
CMPS
180
Compass Pathways
CMPS
$424M
-190,071 Closed -$7.25M
CORT icon
181
Corcept Therapeutics
CORT
$7.35B
0
CRBP icon
182
Corbus Pharmaceuticals
CRBP
$115M
0
CVAC icon
183
CureVac
CVAC
$1.21B
0
CVS icon
184
CVS Health
CVS
$92.8B
0
CVRX icon
185
CVRx
CVRX
$205M
-250,000 Closed -$7M
DGX icon
186
Quest Diagnostics
DGX
$20.3B
0
DHR icon
187
Danaher
DHR
$147B
0
EPIX icon
188
ESSA Pharma
EPIX
$11.4M
-38,803 Closed -$1.11M
EXAS icon
189
Exact Sciences
EXAS
$8.98B
0
EXEL icon
190
Exelixis
EXEL
$10.1B
-51,779 Closed -$943K
FATE icon
191
Fate Therapeutics
FATE
$120M
0
FBRX icon
192
Forte Biosciences
FBRX
$137M
-65,583 Closed -$2.21M
FLGT icon
193
Fulgent Genetics
FLGT
$679M
0
FOLD icon
194
Amicus Therapeutics
FOLD
$2.34B
0
FXD icon
195
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$330M
0
GDX icon
196
VanEck Gold Miners ETF
GDX
$19B
0
GILD icon
197
Gilead Sciences
GILD
$140B
0
GLUE icon
198
Monte Rosa Therapeutics
GLUE
$296M
-100,000 Closed -$2.27M
HCA icon
199
HCA Healthcare
HCA
$94.5B
0
HOLX icon
200
Hologic
HOLX
$14.9B
0